Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis
https://www.ncbi.nlm.nih.gov/m/pubmed/31748904/?i=2&from=hidradenitis%20global%20population
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis
https://www.ncbi.nlm.nih.gov/m/pubmed/31748904/?i=2&from=hidradenitis%20global%20population